GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: WCK 2349 | WCK-2349 | WCK2349
Compound class:
Synthetic organic
Comment: Alalevonadifloxacin is a benzoquinolizine fluoroquinolone class antibacterial. It is being developed as a component of a combination therapy with levonadifloxacin.
|
|
|||||||||||||||||||||||||||||||||||
| No information available. |
Summary of Clinical Use ![]() |
| WCK2349 has completed Phase 1 PK/PD evaluations, but does not appear to have been tested for antibacterial efficacy in infected patients. |
| Clinical Trials | |||||
| Clinical Trial ID | Title | Type | Source | Comment | References |
| NCT02217930 | Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health Volunteers | Phase 1 Interventional | Wockhardt | 1 | |